Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field @josh-hardman.bsky.social chats with Muniz, who recently left his post as Ass. Director @ FDA Division of Psychiatry, about all things psychedelics psychedelicalpha.com/news/inside-...

Updated: The Psychedelic Legalization & Decriminalization Tracker, Now In Partnership with BCSP UC Berkeley’s Center for the Science of Psychedelics joins @calyx.law as a partner on our U.S. psychedelic policy reform tracker. Together, we will maintain this tool, which we first published in 2021.